With GLP‑1 agonist programs expanding rapidly, minimizing analytical uncertainty is essential. Variability or inefficiency in characterization can slow development and increase cost and regulatory risk. Validated workflows help eliminate these bottlenecks.
Access the learning hub to learn about:
- Rapid raw‑material verification: Use spatially offset Raman spectroscopy to identify materials through sealed containers in <40 seconds—cutting handling time and contamination risk.
- Clear insight into degradation pathways: Apply LC/MS with spectral deconvolution to detect oxidation and deamidation products, enabling more reliable stability assessments.
- Accurate isomer differentiation: See how ECD distinguishes Asp/IsoAsp isomers while preserving fatty‑acid side chains for structurally precise characterization.
- Robust, wide‑range bioanalysis: Implement automated sample prep achieving linear quantitation from 0.05–1,000 ng/mL in plasma—improving throughput and reducing manual error.
Explore development‑stage application notes featuring Raman, LC/MS, and ECD methods for confident GLP‑1 agonist peptide assessment.
